title: [Primary hepatotropic viral infections in Mongolia].
abstract: Mongolia is known for its high endemicity for viral hepatitis infections, accounted for 25% of infectious disease cases in 2000. Studies revealed these infections are prevalent among young adults in Mongolia. The infections are first and foremost nosocomial infections. The incidence of primary liver cancer, caused HBV, HDV and HCV chronic infections has increased in the last several years. Although viral hepatitis infections are recognized as a serious health problem in the country, not many epidemiological and clinical studies have been done. Few studies that were done were conducted among limited numbers of high risk subjects. These reports indicated that HBsAg prevalence was between 6.9% and 28.7% and anti-HCV prevalence was between 10.7% and 48% in different population samples and in different years. More studies are needed to determine the real magnitude of hepatitis infections in the general population and to isolate and reduce the exposures specific to at risk population groups. National programs controlling hepatitis infections includes primary prevention strategies such as education, vaccination and infection control particularly in hospital settings, must be implemented to improve the awareness about hepatitis infection especially among youth, women and blood donors.
authors.affiliation: Klinika Chorób Zakaźnych i Hepatologii UM w Łodzi. bomoba@hotmail.com
authors.forename: Boldpioner
authors.initials: B
authors.lastname: Tserenpuntsag
authors.forename: Boldtsetseg
authors.initials: B
authors.lastname: Tserenpuntsag
authors.forename: Jan
authors.initials: J
authors.lastname: Kuydowicz
authors.forename: Elzbieta
authors.initials: E
authors.lastname: Jabłonowska
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000453:epidemiology / Q000382:microbiology; D005260:Female; D006509:Hepatitis B / Q000150:complications / Q000453:epidemiology*; D006526:Hepatitis C / Q000150:complications / Q000453:epidemiology*; D003699:Hepatitis D / Q000150:complications / Q000453:epidemiology*; D006518:Hepatitis Viruses / Q000302:isolation & purification; D006801:Humans; D008113:Liver Neoplasms / Q000453:epidemiology / Q000382:microbiology; D008297:Male; D008986:Mongolia / Q000453:epidemiology; D015995:Prevalence; D012307:Risk Factors; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage
chemical_list: D014761:Viral Hepatitis Vaccines